Inferior control of low-density lipoprotein cholesterol in women is the primary sex difference in modifiable cardiovascular risk: A large-scale, cross-sectional study in primary care
Open Access
- 23 February 2021
- journal article
- research article
- Published by Elsevier BV in Atherosclerosis
- Vol. 324, 141-147
- https://doi.org/10.1016/j.atherosclerosis.2021.02.024
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsJournal of Invasive Cardiology, 2014
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsJournal of the American College of Cardiology, 2014
- Menopause, atherosclerosis, and coronary artery diseaseCurrent Opinion in Pharmacology, 2013
- Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional studyBMJ, 2012
- AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 UpdateJournal of the American College of Cardiology, 2011
- Benefit of Intensive Statin Therapy in WomenCirculation: Cardiovascular Quality and Outcomes, 2011
- Gender Difference in Blood Pressure Control and Cardiovascular Risk Factors in Americans With Diagnosed HypertensionHypertension, 2008
- Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) studyHeart, 2007
- Physicians' attitudes toward preventive therapy for coronary artery disease: Is there a gender bias?Clinical Cardiology, 2005
- External validity of randomised controlled trials: “To whom do the results of this trial apply?”The Lancet, 2005